Cargando…

Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis

BACKGROUND: Randomized controlled trials (RCTs) have reported inconsistent effects from intensified anticoagulation on clinical outcomes in coronavirus disease 2019 (COVID-19). We performed an aggregate data meta-analysis from available trials to quantify effect on nonfatal and fatal outcomes and id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wills, Nicola K, Nair, Nikhil, Patel, Kashyap, Sikder, Omaike, Adriaanse, Marguerite, Eikelboom, John, Wasserman, Sean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214161/ https://www.ncbi.nlm.nih.gov/pubmed/35859991 http://dx.doi.org/10.1093/ofid/ofac285

Ejemplares similares

Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis
por: Wills, Nicola K, et al.
Publicado: (2022)

Efficacy and Safety of Intensified vs Standard Prophylactic Anticoagulation Therapy in Patients Hospitalized With Coronavirus Disease 2019: Updated Systematic Review and Meta-analysis
por: Scheier, Thomas C, et al.
Publicado: (2023)

Venous Thromboembolism in Patients with Human Immunodeficiency Virus
por: Patel, Kashyap, et al.
Publicado: (2023)

Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis
por: Hariharan, Nikhil Nair, et al.
Publicado: (2022)

Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in Coronavirus Disease 2019
por: Motta, Jishu Kaul, et al.
Publicado: (2020)

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
por: Rentsch, Christopher T, et al.
Publicado: (2021)

Prophylactic Anticoagulation in Nephrotic Syndrome
por: Gerstein, Jonathon, et al.
Publicado: (2023)

STANDARD VS HIGH-INTENSITY PROPHYLACTIC ANTICOAGULATION IN COVID-19: A US, CALIFORNIAN RETROSPECTIVE STUDY
por: AHMADI, TAMANA, et al.
Publicado: (2021)

Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation
por: Guo, Zhen, et al.
Publicado: (2021)

Prophylactic anticoagulation for patients in hospital with covid-19
Publicado: (2021)

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022)

An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
por: Alagheband Bahrami, Armina, et al.
Publicado: (2022)

Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
por: Kelddal, Sarah, et al.
Publicado: (2019)

A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome
por: Lin, Raymond, et al.
Publicado: (2019)

Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy
por: Turshudzhyan, Alla
Publicado: (2020)

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
por: Ng, Kuan H., et al.
Publicado: (2013)

Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial
por: Labbe, Vincent, et al.
Publicado: (2022)

Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT
por: Xuan, Li, et al.
Publicado: (2016)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness
por: Komiyama, Maki, et al.
Publicado: (2020)

Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban
por: Eikelboom, John W., et al.
Publicado: (2015)

Statins-based prophylactic mouthwash and nasal spray may protect against coronavirus disease 2019
por: Abdulrab, S., et al.
Publicado: (2020)

Guide to Understanding the 2019 Novel Coronavirus
por: Shah, Aditya, et al.
Publicado: (2020)

Resolution of acute pulmonary embolism using anticoagulation therapy alone in coronavirus disease 2019
por: Ritchie, Charles A., et al.
Publicado: (2022)

Rapid Disappearance of Lupus Anticoagulant in Novel Coronavirus 2019 Patients; Is It the Key to Pandora's Box?
por: Kim, Hyunji, et al.
Publicado: (2021)

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
por: Tang, Ning, et al.
Publicado: (2020)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Fatal retroperitoneal hematoma associated with Covid-19 prophylactic anticoagulation protocol
por: Teta, Michael, et al.
Publicado: (2021)

Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid
por: Kuno, Toshiki, et al.
Publicado: (2021)

The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2020)

The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2021)

Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes
Publicado: (2022)

Value of intensified nursing
por: Frank, Wilhelm, et al.
Publicado: (2006)

Seminar on image intensifiers
por: Klein, Myron W, et al.
Publicado: (1974)

Intensifying vaccine production
Publicado: (2020)

Intensified research on tuberculosis in the Western Pacific Region: a bibliometric analysis, 2000–2019
por: Morishita, Fukushi, et al.
Publicado: (2020)

Tracheostomy for Coronavirus Disease 2019 Patients: Maintaining the Standard of Care
por: Bassily-Marcus, Adel, et al.
Publicado: (2020)

A Review of Cardiac Complications in Coronavirus Disease 2019
por: Singh, Romil, et al.
Publicado: (2020)

Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Moonla, Chatphatai, et al.
Publicado: (2021)

Outpatient Chronic Anticoagulation Improves Outcomes in Patients With Coronavirus Disease 2019 and Cardiovascular Risk Factors
por: Gibson, Andrew K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vsh85ek0be8avkulpjmnmf6cbn